EPO Patents = 2

Forward Citations = 0

Loading Chart...

4 inventors (with patents filed for the assignee):

Yong Hu (5 out of 20 patents)

Miaomiao Zhang (3 out of 5 patents)

Yafei Li (1 out of 2 patents)

4. Zhaoyu Hu (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12454712 - Method for large-scale synthesis of long-chain RNA and method for site-specific modification of long-chain RNA (2025-10-28),

2. 12325676 - Cationic lipid compound and composition for delivery of nucleic acids and use thereof (2025-06-10),

3. 11931410 - SARS-CoV-2 mRNA vaccine and preparation method and use thereof (2024-03-19),

4. 11759532 - mRNA targeting molecule comprising N-acetylgalactosamine binding polypeptide and preparation method therefor (2023-09-19),

5. 11707528 - Mannose-based mRNA targeted delivery system and use thereof (2023-07-25),

Shenzhen Rhegen Biotechnology Co., Ltd. is a leading biotechnology company specializing in the research, development, and production of innovative biopharmaceuticals and diagnostic products. The company focuses on advanced technologies in the fields of molecular biology and genetic engineering, aiming to provide high-quality solutions for healthcare and life sciences. With a commitment to innovation and excellence, Rhegen Biotechnology strives to improve patient outcomes through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#726 in Shenzhen

#4,587 in China

Shenzhen, China

Shenzhen Rhegen Biotechnology Co., Ltd.

Forward Citations = 0

4 inventors:

Yong Hu (5 out of 20 patents)

Miaomiao Zhang (3 out of 5 patents)

Yafei Li (1 out of 2 patents)

4. Zhaoyu Hu (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com